MicroPLUS distinguishes between MCI and Alzheimer'sA recently published paper , "Nanoscale flow cytometry-based quantification of blood-based extracellular vesicle biomarkers distinguishes MCI and Alzheimer's disease" shows that the Apogee Flow MicroPLUS distinguishes between MCI and Alzheimer's.
The publication demonstrates the ability of the 'MicroPLUS' nanoscale particle analyzer to quantify and characterize blood-based extracellular vesicles in order to distinguish between mild cognitive impairment and Alzheimer's disease.
Aug 2024
A recently published paper , "Nanoscale flow cytometry-based quantification of blood-based extracellular vesicle biomarkers distinguishes MCI and Alzheimer's disease" shows that the Apogee Flow MicroPLUS distinguishes between MCI and Alzheimer's.
The publication demonstrates the ability of the 'MicroPLUS' nanoscale particle analyzer to quantify and characterize blood-based extracellular vesicles in order to distinguish between mild cognitive impairment and Alzheimer's disease.
